Skip to main content
. 2021 Mar 19;13(6):1403. doi: 10.3390/cancers13061403

Table 2.

Association between DCBLD2 expression and clinicopathological features of patients with LUAD from Tianjin Medical University Cancer Institute and Hospital. Cut off: H score = 5, * p < 0.05, ** p < 0.01, Chi-square test, except for #: Fisher test.

Characteristics Total
(n = 125)
DCBLD2 Expression χ2 p Value
Low (n = 37) High (n = 88)
Gender 1.926 0.165
Male 59 21 38
Female 66 16 50
Age (year) 0.826 0.363
<65 91 29 62
≥65 34 8 26
T staging 0.409 0.523
T1 52 17 35
T2–T4 73 20 53
Nodal staging 7.119 0.008 **
N0–N1 83 31 52
N2–N3 42 6 36
M staging 1.000 #
M0 124 37 87
M1 1 0 1
TNM 6.406 0.011 *
I 56 23 33
II,III,IV 69 14 55